2053-8790

Lupus Science & Medicine

BMJ

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add license metadata to 219 records

License metadata tells indexers and readers how each article may be reused.

Low impact219 DOIs
2

Attach ORCID iDs across 175 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact175 DOIs
3

Add abstracts to 79 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact79 DOIs

DOIs for this ISSN

Showing the top 5 of 874 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Alopecias in lupus erythematosus (10.1136/lupus-2018-000291)
References ORCID License
135.46 63
2 Molecular signatures in systemic lupus erythematosus: distin… (10.1136/lupus-2016-000159)
Abstract ORCID License
119.33 38
3 Haematological manifestations of lupus (10.1136/lupus-2014-000078)
ORCID License
119.01 239
4 A proteinuria cut-off level of 0.7 g/day after 12 months of… (10.1136/lupus-2015-000123)
ORCID License
117.12 219
5 Effect of corticosteroid use by dose on the risk of developi… (10.1136/lupus-2014-000066)
ORCID License
113.48 185
6 Mouse models of lupus: what they tell us and what they don’t (10.1136/lupus-2016-000199)
ORCID License
111.65 170
7 Lupus anticoagulant is the main predictor of adverse pregnan… (10.1136/lupus-2015-000131)
ORCID License
108.22 145
8 Characterisation of anifrolumab, a fully human anti-interfer… (10.1136/lupus-2018-000261)
ORCID License
107.31 139
9 Association of the interferon signature metric with serologi… (10.1136/lupus-2014-000080)
ORCID License
106.36 133
10 Role of early repeated renal biopsies in lupus nephritis (10.1136/lupus-2014-000018)
ORCID License
105.19 126
11 Response to belimumab among patients with systemic lupus ery… (10.1136/lupus-2015-000118)
ORCID License
103.59 117
12 Type I interferons in host defence and inflammatory diseases (10.1136/lupus-2019-000336)
ORCID License
102.27 110
13 Independent association of glucocorticoids with damage accru… (10.1136/lupus-2016-000157)
ORCID License
100.85 103
14 Early proteinuria response: a valid real-life situation pred… (10.1136/lupus-2017-000213)
ORCID License
100.43 101
15 SLE: reconciling heterogeneity (10.1136/lupus-2018-000280)
Abstract ORCID License
99.17 20
16 Placental histology and neutrophil extracellular traps in lu… (10.1136/lupus-2015-000134)
ORCID License
99.11 95
17 Current and future therapies for SLE: obstacles and recommen… (10.1136/lupus-2017-000239)
ORCID License
98.66 93
18 Correction: 2021 DORIS definition of remission in SLE: final… (10.1136/lupus-2021-000538corr1)
Abstract References ORCID
97.58 19
19 DNA methylation patterns in naïve CD4+ T cells identify epig… (10.1136/lupus-2015-000101)
ORCID License
96.72 85
20 Remission and low disease activity in systemic lupus erythem… (10.1136/lupus-2017-000234)
ORCID License
94.60 77
21 Anifrolumab effects on rash and arthritis: impact of the typ… (10.1136/lupus-2018-000284)
ORCID License
94.32 76
22 Observational studies on glucocorticoids are harmful! (10.1136/lupus-2017-000219)
Abstract ORCID License
94.15 17
23 Clinical, laboratory and health-related quality of life corr… (10.1136/lupus-2014-000031)
ORCID License
94.04 75
24 Cell-bound complement activation products in systemic lupus… (10.1136/lupus-2014-000056)
ORCID License
94.04 75
25 DNA methylation 101: what is important to know about DNA met… (10.1136/lupus-2018-000285)
ORCID License
94.04 75
26 Inducible T-cell co-stimulator ligand (ICOSL) blockade leads… (10.1136/lupus-2016-000146)
ORCID License
92.56 70
27 Systemic lupus erythematosus complicated by diffuse alveolar… (10.1136/lupus-2015-000117)
ORCID License
92.25 69
28 Associates and predictors of pleurisy or pericarditis in SLE (10.1136/lupus-2017-000221)
ORCID License
92.25 69
29 Association of low vitamin D with high disease activity in a… (10.1136/lupus-2014-000064)
ORCID License
91.94 68
30 Lupus community panel proposals for optimising clinical tria… (10.1136/lupus-2018-000258)
ORCID License
91.30 66
31 Cardiovascular events prior to or early after diagnosis of s… (10.1136/lupus-2015-000143)
ORCID License
90.98 65
32 Safety, pharmacokinetics and pharmacodynamics of AMG 811, an… (10.1136/lupus-2017-000226)
ORCID License
90.31 63
33 Risk factors for osteoporosis and fragility fractures in pat… (10.1136/lupus-2015-000098)
ORCID License
89.97 62
34 Which outcome measures in SLE clinical trials best reflect m… (10.1136/lupus-2013-000005)
ORCID License
89.27 60
35 Disease activity patterns over time in patients with SLE: an… (10.1136/lupus-2016-000192)
ORCID License
88.91 59
36 Work disability, lost productivity and associated risk facto… (10.1136/lupus-2014-000058)
ORCID License
88.17 57
37 Lupus anticoagulant, disease activity and low complement in… (10.1136/lupus-2015-000095)
ORCID License
86.62 53
38 Reduced response to Epstein–Barr virus antigens by T-cells i… (10.1136/lupus-2014-000015)
ORCID License
86.21 52
39 Lower vitamin D levels are associated with higher systemic l… (10.1136/lupus-2014-000027)
ORCID License
85.80 51
40 Safety and efficacy of hCDR1 (Edratide) in patients with act… (10.1136/lupus-2015-000104)
ORCID License
85.80 51
41 Presentation of SLE in UK primary care using the Clinical Pr… (10.1136/lupus-2016-000172)
ORCID License
85.38 50
42 Obstetric antiphospholipid syndrome (10.1136/lupus-2016-000197)
ORCID License
85.38 50
43 Cell-bound complement activation products in SLE (10.1136/lupus-2017-000236)
ORCID License
85.38 50
44 I too, am America: a review of research on systemic lupus er… (10.1136/lupus-2015-000144)
ORCID License
84.51 48
45 Genome-wide profiling identifies associations between lupus… (10.1136/lupus-2016-000183)
ORCID License
84.51 48
46 Is frailty a relevant concept in SLE? (10.1136/lupus-2016-000186)
ORCID License
84.51 48
47 BAFF (B cell activating factor) transcript level in peripher… (10.1136/lupus-2014-000063)
ORCID License
81.67 42
48 Characterising the immune profile of the kidney biopsy at lu… (10.1136/lupus-2015-000112)
ORCID License
81.67 42
49 Brain metabolism and autoantibody titres predict functional… (10.1136/lupus-2014-000074)
ORCID License
81.16 41
50 Identification of clinical and serological factors during in… (10.1136/lupus-2015-000089)
ORCID License
81.16 41